Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Express Scripts
Chinese Patent Office
Colorcon
Covington
Farmers Insurance
Julphar
Chubb
Cantor Fitzgerald

Generated: June 23, 2018

DrugPatentWatch Database Preview

HYDROXYZINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Hydroxyzine patents expire, and when can generic versions of Hydroxyzine launch?

Hydroxyzine is a drug marketed by Baxter Hlthcare, Altana, Fresenius Kabi Usa, Hospira, Luitpold, Pharmafair, Smith And Nephew, Solopak, Watson Labs, Wyeth Ayerst, Alpharma Us Pharms, Hi Tech Pharma, Kv Pharm, Lannett Co Inc, Sti Pharma Llc, Vintage Pharms, Wockhardt Bio Ag, Able, Actavis Elizabeth, Amneal Pharm, Aurolife Pharma Llc, Eci Pharms Llc, Elite Labs Inc, Halsey, Heritage Pharma, Hetero Labs Ltd Iii, Invagen Pharms, Ivax Pharms, Kvk Tech, Mutual Pharm, Mylan, Northstar Hlthcare, Nuvo Pharm, Nuvo Pharm Inc, Pliva, Prinston Inc, Purepac Pharm, Quantum Pharmics, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Usl Pharma, Vintage, Barr, Duramed Pharms Barr, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, and Vangard. and is included in one hundred and thirty-eight NDAs.

The generic ingredient in HYDROXYZINE is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.
Summary for HYDROXYZINE
Drug patent expirations by year for HYDROXYZINE
Synonyms for HYDROXYZINE
0635AC
1-(4-Chloro-alpha-phenylbenzyl)-4-((2-(2-hydroxyethoxy)ethyl)piperazine)
1-(p-Chloro-.alpha.-phenylbenzyl)-4-(2-((2-hydroxyethoxy)ethyl)piperazine
1-(p-Chloro-.alpha.-phenylbenzyl)-4-[2-[(2-hydroxyethoxy)ethyl]piperazine
1-(p-Chloro-alpha-phenylbenzyl)-4-(2-(2-hydroxyethoxy)ethyl)piperazine
1-(p-Chloro-alpha-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine
1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine
1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)piperazine
1-(p-Chlorobenzhydryl)-4-[2-(2-hydroxyethoxy)ethyl]diethylenediamine
1-(p-Chlorobenzhydryl)-4-[2-(2-hydroxyethoxy)ethyl]piperazine
1-(p-Chlorodiphenylmethyl)-4-(2-(2-hydroxyethoxy)ethyl)piperazine
1-(p-Chlorodiphenylmethyl)-4-[2-(2-hydroxyethoxy)ethyl]piperazine
10246-75-0 (pamoate)
2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol
2-(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol
2-(2-(4-(p-Chloro-.alpha.-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol
2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol
2-(2-(4-[(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl)ethoxy)ethanol #
2-(2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-ethanol
2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethan-1-ol
2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethanol
2-(2-{4-[(4-chlorophenyl)phenylmethyl]piperazinyl}ethoxy)ethan-1-ol
2-[(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]ethanol
2-[2-[4-(p-Chloro-.alpha.-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol
2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]ethanol
2192-20-3 (di-hydrochloride)
24155-EP2275420A1
24155-EP2295409A1
24155-EP2298764A1
24155-EP2298765A1
24155-EP2314590A1
242H772
5-23-01-00462 (Beilstein Handbook Reference)
68-88-2
AB00053485
AB00053485_24
AB00053485_25
AC1L1GFB
AK116467
AKOS003334349
AKOS016843978
AN-41909
API0000603
Atara
Atarax
Atarax (Salt/Mix)
Atarax (TN)
Atarax base
Ataraxoid
Atarazoid
Atarox
Atazina
Aterax
AX8050929
BBL034752
BC252494
BDBM22875
BPBio1_000228
BRD-A62428732-096-02-6
BRD-A62428732-300-03-0
BRN 0321392
BSPBio_000206
C07045
C21H27ClN2O2
CAS-68-88-2
CHEBI:5818
CHEMBL896
CS-2650
CTK8G0241
D08054
D0O6SX
DB00557
Deinait
Disron (Salt/Mix)
DSSTox_CID_3137
DSSTox_GSID_23137
DSSTox_RID_76887
DTXSID8023137
Durrax
Durrax (Salt/Mix)
EINECS 200-693-1
ETH012
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)- (9CI)
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-(9CI)
Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-
Ethanol, 2-[2-[4-(p-chloro-.alpha.-phenylbenzyl)-1-piperazinyl]ethoxy]-
Ethanol, 2-[2-[4-(p-chloro-phenylbenzyl)-1-piperazinyl]ethoxy]-
Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-
Ethanol,2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-
Fenarol
FT-0670239
GTPL7199
HE065373
HE379983
Hidroxizina
Hidroxizina [INN-Spanish]
HMS3604B10
HSDB 3098
HY-B0548
Hy-Pam 25
Hychotine
Hydroksyzyny
Hydroksyzyny [Polish]
Hydroxine
Hydroxizine
Hydroxizinum
Hydroxycine
Hydroxyzin
Hydroxyzine (INN)
Hydroxyzine [INN:BAN]
Hydroxyzine base
Hydroxyzine Hcl
Hydroxyzine hydrochloride
Hydroxyzine, (R)
Hydroxyzinum
Hydroxyzinum [INN-Latin]
Hydroxyzyne
Idrossizina
Idrossizina [DCIT]
KB-296265
KS-000019VL
L000930
LS-66601
Marex (TN)
MFCD00242772
MolPort-002-506-318
MRF-0000015
N-(4-Chlorobenzhydryl)-N'-(hydroxyethoxyethyl)piperazine
N-(4-Chlorobenzhydryl)-N'-(hydroxyethyloxyethyl)piperazine
NCGC00018255-02
NCGC00018255-03
NCGC00018255-04
NCGC00018255-06
NCGC00021152-06
NCGC00089816-03
neo-Calma
Neurozina
Nevrolaks
NP 212
NSC 169188
NSC-169188
NSC169188
Orgatrax
Pamazone
Parenteral
Paxistil
Placidol
Plaxidol
Prestwick0_000133
Prestwick1_000133
Prestwick2_000133
Prestwick3_000133
SCHEMBL4491
SPBio_002145
ST059726
STL417960
Tox21_113569
Tox21_113569_1
Tran-Q
Tranquizine
Traquizine
U.C.B 4492
U.CB 4492
UCB 4492
UCB 492
UCB-4492
Vesparaz-Wirkstoff
Vistaril
Vistaril (Salt/Mix)
Vistaril (TN)
WLN: T6N DNTJ AYR&R D6& D2O2Q
ZQDWXGKKHFNSQK-UHFFFAOYSA-N

US Patents and Regulatory Information for HYDROXYZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 087820-001 Jun 23, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Quantum Pharmics HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 088551-001 Oct 22, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Elizabeth HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 089071-001 Jul 22, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hi Tech Pharma HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride SYRUP;ORAL 040010-001 Oct 28, 1994 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Johnson and Johnson
US Army
AstraZeneca
Boehringer Ingelheim
Fish and Richardson
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.